Regado Biosciences announces closing of public offering of common stock
Regado Biosciences announced the closing of its underwritten public offering. Gross proceeds to Regado from its sale of 10,000,000 shares of common stock at a price to the public of $6.00 per share were $60.0 million, prior to deducting underwriting expenses. April 16, 2014